1. Home
  2. ABCL vs MAN Comparison

ABCL vs MAN Comparison

Compare ABCL & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.87

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$33.72

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
MAN
Founded
2012
1948
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ABCL
MAN
Price
$7.87
$33.72
Analyst Decision
Strong Buy
Hold
Analyst Count
5
6
Target Price
$8.40
$35.67
AVG Volume (30 Days)
7.1M
1.1M
Earning Date
05-11-2026
04-16-2026
Dividend Yield
N/A
4.69%
EPS Growth
10.91
N/A
EPS
N/A
0.05
Revenue
$75,128,000.00
$17,957,100,000.00
Revenue This Year
N/A
$5.12
Revenue Next Year
$21.85
$3.42
P/E Ratio
N/A
$675.40
Revenue Growth
160.56
0.58
52 Week Low
$2.75
$25.15
52 Week High
$8.42
$47.34

Technical Indicators

Market Signals
Indicator
ABCL
MAN
Relative Strength Index (RSI) 73.27 53.65
Support Level $3.32 $28.29
Resistance Level N/A $36.87
Average True Range (ATR) 0.53 1.64
MACD 0.24 0.04
Stochastic Oscillator 83.58 38.49

Price Performance

Historical Comparison
ABCL
MAN

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

Share on Social Networks: